Laboratorios Rety de Colombia S A SDecember 6, 2019

FDA 483 - Laboratorios Rety de Colombia S A S - December 06, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Laboratorios Rety de Colombia S A S

Record Details

An FDA inspection of Laboratorios Rety de Colombia S A S in Barranquilla, Colombia, revealed two significant observations. The firm failed to perform assay testing for finished drug products prior to release, relying instead on bulk product testing without scientific justification. Additionally, control procedures for manufacturing processes were found to be inadequate, specifically regarding the validation of critical process parameters.

Company: Laboratorios Rety de Colombia S A S
Inspection Date: December 6, 2019
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Marian E. Ramirez (investigator)

Open in Dashboard

ID · f36de1a9-42a0-4be8-96f6-f84b7c3af4bd